This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Beckman Research Institute, City of Hope, City of Hope. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Marissa M Del Real: Innovator in Cancer Treatment
Introduction
Marissa M Del Real is a prominent inventor based in Duarte, California. She has made significant contributions to the field of cancer treatment through her innovative research and development of targeted therapies. Her work focuses on improving the efficacy of treatments for malignancies, particularly those that express the CD33 antigen.
Latest Patents
Marissa holds a patent for her invention titled "CD33 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF CD33 POSITIVE MALIGNANCIES." This groundbreaking patent represents her commitment to advancing cancer therapies and offers new hope for patients with CD33 positive malignancies. She has 1 patent to her name, showcasing her innovative approach to medical science.
Career Highlights
Marissa is currently affiliated with City of Hope, a leading research and treatment center dedicated to cancer and other life-threatening diseases. Her role at City of Hope allows her to collaborate with other experts in the field and contribute to cutting-edge research that aims to improve patient outcomes.
Collaborations
Throughout her career, Marissa has worked alongside esteemed colleagues, including Tongyuan Xue and Lihua Elizabeth Budde. These collaborations have further enriched her research and have been instrumental in the development of her innovative therapies.
Conclusion
Marissa M Del Real is a trailblazer in the field of cancer treatment, with her innovative patent and collaborative efforts paving the way for advancements in targeted therapies. Her dedication to improving patient care through scientific innovation is commendable and continues to inspire others in the medical research community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
